InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Kramer Robert, Chief Executive Officer. Director active across 1 companies, notably Emergent BioSolutions Inc.. In total, 5 filings have been recorded. The latest transaction was filed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
033,833 shares0
Common Stock
SEC:0001367644-22-000044:0·
€52,8941,419 shares@ €37.27560.013% mcap84.6% of flow
Common Stock
SEC:0001367644-22-000031:0·
04,264 shares0
Common Stock
SEC:0001367644-22-000022:0·
€4,79994 shares@ €51.05830.0012% mcap100.0% of flow
Common Stock
SEC:0001367644-21-000077·
€4,79994 shares@ €51.05830.0012% mcap7.7% of flow
Common Stock
SEC:0001367644-21-000077:0·
5 of 5 declarations
About Kramer Robert
Robert Kramer is the President and CEO of Emergent BioSolutions Inc. He is responsible for the strategic direction and overall management of the company.
